Essential Partners’s Outset Medical OM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$429 Sell
143
-261
-65% -$1.06K ﹤0.01% 2439
2026
Q2
$1.74K Sell
404
-2,101
-84% -$9.19K ﹤0.01% 2034
2026
Q1
$9.6K Buy
2,505
+2,383
+1,953% +$9.8K ﹤0.01% 1276
2025
Q4
$453 Buy
122
+110
+917% +$944 ﹤0.01% 2252
2025
Q3
$169 Buy
+12
New +$187 ﹤0.01% 2421

Other funds holding OM

Essential Partners's OM Position: Q3 2026 in Review

Essential Partners reduced its Outset Medical (OM) stake by 65% in Q3 2026, selling an estimated $1.06K and leaving 143 shares worth $429. The position accounts for ﹤0.01% of the portfolio, ranked #2439.

Essential Partners first reported a position in OM in Q3 2025 and has held it in 5 quarters since. The position peaked at $9.6K in Q1 2026. 8 funds tracked by Wall St. Rank hold OM as of Q3 2026.

  • Essential Partners held 143 shares of Outset Medical worth $429 as of Q3 2026.
  • Essential Partners sold 261 Outset Medical shares in Q3 2026, an estimated $1.06K.
  • Outset Medical made up ﹤0.01% of Essential Partners's portfolio in Q3 2026, its #2439 holding.
  • Essential Partners first reported a position in Outset Medical in Q3 2025 and has held it in 5 quarters since.
  • Essential Partners's Outset Medical position peaked at $9.6K in Q1 2026.
  • 8 funds tracked by Wall St. Rank held Outset Medical as of Q3 2026.

Based on Essential Partners's 13F filing for Q3 2026, filed 14 Oct 2026.